NeRRe Therapeutics raises £20 million in a Series B2 financing round

Ads

You May Also Like

AngioDynamics to Report Fiscal 2016 Second Quarter Financial Results

ALBANY, N.Y., Dec. 28, 2015 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, ...

RedHill Biopharma Provides 2017 Year-End Business Update

TEL-AVIV, Israel and RALEIGH, N.C., Dec. 05, 2017 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. ...

Celyad Reports First Half 2016 Financial Results and Operational Progress

MONT-SAINT-GUIBERT, Belgium, Aug. 25, 2016 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels and Paris, and ...